In the BioHarmony Drug Report Database
Oraverse, Regitine (phentolamine) is a small molecule pharmaceutical. Phentolamine was first approved as Oraverse on 1982-01-01. It is used to treat extravasation of diagnostic and therapeutic materials, malignant hypertension, and necrosis in the USA. The pharmaceutical is active against alpha-1B adrenergic receptor, alpha-1D adrenergic receptor, and alpha-1A adrenergic receptor. In addition, it is known to target alpha-2B adrenergic receptor, alpha-2C adrenergic receptor, and alpha-2A adrenergic receptor. Phentolamine mesylate’s patents are valid until 2025-04-21 (FDA).
Image (chem structure or protein)